<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shi Z</submitter><funding>the Xinjiang Tianshan Talent Training Program Grant</funding><funding>the National Natural Science Foundation of China regional project</funding><funding>the Xinjiang Natural Science Foundation for Distinguished Young Scholars</funding><pagination>179</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11488200</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>30(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Docetaxel (DTX) resistance attenuates anti-tumor effects of DTX on prostate cancer (mCRPC) and drug resistance was related to Treg expansion in tumors. ZNF667-AS1 played a suppressing role in various tumors and tumor-derived exosomes carry lncRNAs to participate in tumor progression. Here, the effects of ZNF667-AS1 on malignant characteristics and DTX resistance in PC and the effect and its underlying molecular mechanism of tumor-derived exosomes carrying ZNF667-AS1 on Treg expansion were investigated.&lt;h4>Methods&lt;/h4>The identification of exosomes were determined using TEM, NTA and western blot. The abundance of genes and proteins were evaluated using IHC, RT-qPCR, western blot and FISH. Malignant phenotypes of PC cells were evaluated by means of Edu, scratch test, trans</pubmed_abstract><journal>Molecular medicine (Cambridge, Mass.)</journal><pubmed_title>Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1.</pubmed_title><pmcid>PMC11488200</pmcid><funding_grant_id>82360520</funding_grant_id><funding_grant_id>2023TSYCCX0061</funding_grant_id><funding_grant_id>2022D01E84</funding_grant_id><pubmed_authors>Sun M</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Aihemaitijiang M</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Pu W</pubmed_authors><pubmed_authors>Liu B</pubmed_authors><pubmed_authors>Shi Z</pubmed_authors><pubmed_authors>Li M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1.</name><description>&lt;h4>Background&lt;/h4>Docetaxel (DTX) resistance attenuates anti-tumor effects of DTX on prostate cancer (mCRPC) and drug resistance was related to Treg expansion in tumors. ZNF667-AS1 played a suppressing role in various tumors and tumor-derived exosomes carry lncRNAs to participate in tumor progression. Here, the effects of ZNF667-AS1 on malignant characteristics and DTX resistance in PC and the effect and its underlying molecular mechanism of tumor-derived exosomes carrying ZNF667-AS1 on Treg expansion were investigated.&lt;h4>Methods&lt;/h4>The identification of exosomes were determined using TEM, NTA and western blot. The abundance of genes and proteins were evaluated using IHC, RT-qPCR, western blot and FISH. Malignant phenotypes of PC cells were evaluated by means of Edu, scratch test, trans</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2025-04-04T02:21:16.075Z</modification><creation>2025-04-04T02:21:16.075Z</creation></dates><accession>S-EPMC11488200</accession><cross_references><pubmed>39425009</pubmed><doi>10.1186/s10020-024-00947-z</doi></cross_references></HashMap>